Kristina Bowen, MD
Duke University School of Medicine in Durham, NC
Duke University Medical Center in Durham, NC
Duke University Medical Center in Durham, NC; Emory University School of Medicine in Atlanta, GA
Management of breast cancer and chemoprevention for women at high risk
Dr. Bowen was voted an Atlanta Top Doctor in 2016, 2017, and 2018 and is a member of the American Society of Clinical Oncology. She was the first author and presented a poster at the ASCO meeting in 2012, “Evaluation of Variables that May Impact Chemotherapy Administration after Determination of Oncotype DX Recurrence Score Results.” This study analyzed the use of the Oncotype DX assay in a large group of GCS patients with early stages of breast cancer (788 eligible patients across the practice). It also analyzed the circumstances under which the test was ordered, and how the test results were utilized in making chemotherapy treatment decisions. The analysis demonstrated that Oncotype DX results are being used appropriately in guiding treatment recommendations for GCS patients, thus confirming the utility of the Oncotype DX test in our practice. She achieved an undergraduate degree in Molecular Biophysics and Biochemistry at Yale University.